Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the Plan) notified the Company and the under-mentioned persons on 19 July 2012 of an increase in their interests in Ordinary Shares and American Depositary Shares (ADSs) at a price of 1470 pence per Ordinary Share and $46.27 per ADS following the re-investment of dividends paid to shareholders on 5 July 2012.
|
|
Mrs D P Connelly |
Acquisition of 24.671 ADSs under the personal contribution element of the Plan. |
|
|
|
Acquisition of 24.684 ADSs under the matching element of the Plan (Company contribution). |
|
|
Mr M Dunoyer |
Acquisition of 24.760 Ordinary Shares under the personal contribution element of the Plan.
|
|
Acquisition of 34.393 Ordinary Shares under the matching element of the Plan (Company contribution). |
|
|
Mr W C Louv |
Acquisition of 26.147 ADSs under the personal contribution element of the Plan.
|
|
Acquisition of 26.175 ADSs under the matching element of the Plan (Company contribution).
|
The afore-mentioned individuals have elected to participate in the Plan in respect of their 2010 and 2011 bonus on a post-tax basis. The notional dividends accrued under the matching element will be paid out in proportion to the percentage of the participant's deferred annual bonus matching award holdings that will vest following the end of the relevant three year measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
19 July 2012